HSBC retained its 'Buy' rating on Apollo and KIMS. It raised the price targets on Rainbow and Aster due to a significant capex cycle for hospitals expected by 2025. The brokerage noted persistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback